FDA Considers Regulating Homeopathic Products

at 9:00 AM
Save ArticleSave Article

Failed to save article

Please try again

This article is more than 7 years old.
 (Getty Images)

The Food and Drug Administration began hearings Monday on the regulation and marketing of homeopathic products. Homeopathy is based on the notion that illnesses can be cured by highly diluted doses of the substance causing the illness. At issue is whether or not these remedies should go through a drug approval process similar to conventional treatments. Considered a pseudo-science by the medical establishment, patients and practitioners swear by the efficacy of homeopathy. We'll get an update on the hearings and discuss whether or not the FDA should regulate homeopathic products.


Cynthia Schnedar, director of the Office of Compliance at the Center for Drug Evaluation and Research

Karen Allen, board member of the Integrative Health Policy Consortium

Adriane Fugh-Berman, associate professor of pharmacology at Georgetown University